HRP20080064T5 - Prodrugs of piperazine and substituted piperidine antiviral agents - Google Patents
Prodrugs of piperazine and substituted piperidine antiviral agentsInfo
- Publication number
- HRP20080064T5 HRP20080064T5 HR20080064T HRP20080064T HRP20080064T5 HR P20080064 T5 HRP20080064 T5 HR P20080064T5 HR 20080064 T HR20080064 T HR 20080064T HR P20080064 T HRP20080064 T HR P20080064T HR P20080064 T5 HRP20080064 T5 HR P20080064T5
- Authority
- HR
- Croatia
- Prior art keywords
- group
- phenyl
- pyridinyl
- heteroaryl
- methoxy
- Prior art date
Links
- GLUUGHFHXGJENI-UHFFFAOYSA-N Piperazine Chemical compound C1CNCCN1 GLUUGHFHXGJENI-UHFFFAOYSA-N 0.000 title 2
- 239000003443 antiviral agent Substances 0.000 title 1
- 150000003053 piperidines Chemical class 0.000 title 1
- 229940002612 prodrug Drugs 0.000 title 1
- 239000000651 prodrug Substances 0.000 title 1
- NQRYJNQNLNOLGT-UHFFFAOYSA-N tetrahydropyridine hydrochloride Natural products C1CCNCC1 NQRYJNQNLNOLGT-UHFFFAOYSA-N 0.000 title 1
- 229910052736 halogen Inorganic materials 0.000 abstract 6
- 150000002367 halogens Chemical class 0.000 abstract 6
- 125000001072 heteroaryl group Chemical group 0.000 abstract 5
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 abstract 5
- 125000004076 pyridyl group Chemical group 0.000 abstract 4
- 125000001424 substituent group Chemical group 0.000 abstract 4
- -1 -amino Chemical group 0.000 abstract 3
- 229910052739 hydrogen Inorganic materials 0.000 abstract 3
- 239000001257 hydrogen Substances 0.000 abstract 3
- 125000004435 hydrogen atom Chemical class [H]* 0.000 abstract 3
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 abstract 3
- 125000002541 furyl group Chemical group 0.000 abstract 2
- 125000000842 isoxazolyl group Chemical group 0.000 abstract 2
- 125000000956 methoxy group Chemical group [H]C([H])([H])O* 0.000 abstract 2
- 125000001715 oxadiazolyl group Chemical group 0.000 abstract 2
- 125000002971 oxazolyl group Chemical group 0.000 abstract 2
- 125000001544 thienyl group Chemical group 0.000 abstract 2
- 125000004169 (C1-C6) alkyl group Chemical group 0.000 abstract 1
- 125000003342 alkenyl group Chemical group 0.000 abstract 1
- 125000005334 azaindolyl group Chemical group N1N=C(C2=CC=CC=C12)* 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 125000004093 cyano group Chemical group *C#N 0.000 abstract 1
- 125000002147 dimethylamino group Chemical group [H]C([H])([H])N(*)C([H])([H])[H] 0.000 abstract 1
- 125000002183 isoquinolinyl group Chemical group C1(=NC=CC2=CC=CC=C12)* 0.000 abstract 1
- 125000000250 methylamino group Chemical group [H]N(*)C([H])([H])[H] 0.000 abstract 1
- 125000004593 naphthyridinyl group Chemical group N1=C(C=CC2=CC=CN=C12)* 0.000 abstract 1
- 125000004592 phthalazinyl group Chemical group C1(=NN=CC2=CC=CC=C12)* 0.000 abstract 1
- 125000003226 pyrazolyl group Chemical group 0.000 abstract 1
- 125000000714 pyrimidinyl group Chemical group 0.000 abstract 1
- 125000002294 quinazolinyl group Chemical group N1=C(N=CC2=CC=CC=C12)* 0.000 abstract 1
- 125000002943 quinolinyl group Chemical group N1=C(C=CC2=CC=CC=C12)* 0.000 abstract 1
- 125000001567 quinoxalinyl group Chemical group N1=C(C=NC2=CC=CC=C12)* 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 125000001425 triazolyl group Chemical group 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/06—Phosphorus compounds without P—C bonds
- C07F9/08—Esters of oxyacids of phosphorus
- C07F9/09—Esters of phosphoric acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
- A61K31/675—Phosphorus compounds having nitrogen as a ring hetero atom, e.g. pyridoxal phosphate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/4965—Non-condensed pyrazines
- A61K31/497—Non-condensed pyrazines containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C215/00—Compounds containing amino and hydroxy groups bound to the same carbon skeleton
- C07C215/02—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton
- C07C215/04—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being saturated
- C07C215/06—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being saturated and acyclic
- C07C215/10—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being saturated and acyclic with one amino group and at least two hydroxy groups bound to the carbon skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/06—Phosphorus compounds without P—C bonds
- C07F9/062—Organo-phosphoranes without P-C bonds
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/553—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having one nitrogen atom as the only ring hetero atom
- C07F9/572—Five-membered rings
- C07F9/5728—Five-membered rings condensed with carbocyclic rings or carbocyclic ring systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/655—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having oxygen atoms, with or without sulfur, selenium, or tellurium atoms, as the only ring hetero atoms
- C07F9/65515—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having oxygen atoms, with or without sulfur, selenium, or tellurium atoms, as the only ring hetero atoms the oxygen atom being part of a five-membered ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/6558—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing at least two different or differently substituted hetero rings neither condensed among themselves nor condensed with a common carbocyclic ring or ring system
- C07F9/65586—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing at least two different or differently substituted hetero rings neither condensed among themselves nor condensed with a common carbocyclic ring or ring system at least one of the hetero rings does not contain nitrogen as ring hetero atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/6561—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing systems of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring or ring system, with or without other non-condensed hetero rings
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Virology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Tropical Medicine & Parasitology (AREA)
- AIDS & HIV (AREA)
- Engineering & Computer Science (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Hydrogenated Pyridines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US55332004P | 2004-03-15 | 2004-03-15 | |
US63523104P | 2004-12-10 | 2004-12-10 | |
PCT/US2005/006980 WO2005090367A1 (en) | 2004-03-15 | 2005-03-03 | Prodrugs of piperazine and substituted piperidine antiviral agents |
Publications (2)
Publication Number | Publication Date |
---|---|
HRP20080064T3 HRP20080064T3 (en) | 2008-03-31 |
HRP20080064T5 true HRP20080064T5 (en) | 2008-10-31 |
Family
ID=34963934
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HR20080064T HRP20080064T5 (en) | 2004-03-15 | 2008-02-11 | Prodrugs of piperazine and substituted piperidine antiviral agents |
Country Status (27)
Country | Link |
---|---|
US (12) | US7745625B2 (xx) |
EP (1) | EP1725569B1 (xx) |
JP (1) | JP4734318B2 (xx) |
KR (1) | KR101153594B1 (xx) |
CN (1) | CN101941990B (xx) |
AR (1) | AR048039A1 (xx) |
AT (1) | ATE384728T1 (xx) |
AU (1) | AU2005223736C1 (xx) |
BR (1) | BRPI0508876B8 (xx) |
CA (1) | CA2560253C (xx) |
CY (1) | CY1107419T1 (xx) |
DE (1) | DE602005004517T2 (xx) |
DK (1) | DK1725569T3 (xx) |
ES (1) | ES2299022T3 (xx) |
GE (1) | GEP20094736B (xx) |
HK (2) | HK1096687A1 (xx) |
HR (1) | HRP20080064T5 (xx) |
IL (1) | IL211961A (xx) |
MY (1) | MY139243A (xx) |
NO (1) | NO336742B1 (xx) |
NZ (2) | NZ549867A (xx) |
PE (1) | PE20051151A1 (xx) |
PL (1) | PL1725569T3 (xx) |
PT (1) | PT1725569E (xx) |
RS (1) | RS50567B (xx) |
TW (1) | TWI344843B (xx) |
WO (1) | WO2005090367A1 (xx) |
Families Citing this family (67)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20040110785A1 (en) * | 2001-02-02 | 2004-06-10 | Tao Wang | Composition and antiviral activity of substituted azaindoleoxoacetic piperazine derivatives |
TWI329105B (en) | 2002-02-01 | 2010-08-21 | Rigel Pharmaceuticals Inc | 2,4-pyrimidinediamine compounds and their uses |
MXPA05001096A (es) * | 2002-07-29 | 2005-11-23 | Rigel Pharmaceuticals Inc | Metodos para tratamiento o prevencion de enfermedades autoinmunes con compuestos de 2,4-diamino-pirimidina. |
US20050075364A1 (en) * | 2003-07-01 | 2005-04-07 | Kap-Sun Yeung | Indole, azaindole and related heterocyclic N-substituted piperazine derivatives |
KR20120062863A (ko) * | 2003-07-30 | 2012-06-14 | 리겔 파마슈티칼스, 인크. | 자가면역 질환의 치료 또는 예방에 사용하기 위한 2,4-피리미딘디아민 화합물 |
US7745625B2 (en) * | 2004-03-15 | 2010-06-29 | Bristol-Myers Squibb Company | Prodrugs of piperazine and substituted piperidine antiviral agents |
US7130185B2 (en) * | 2004-06-02 | 2006-10-31 | Research In Motion Limited | Handheld computing device having drop-resistant LCD display |
US20060100209A1 (en) * | 2004-11-09 | 2006-05-11 | Chong-Hui Gu | Formulations of 1-(4-benzoyl-piperazin-1-yl)-2-[4-methoxy-7-(3-methyl-[1,2,4]triazol-1-yl)-1H-pyrrolo[2,3-c]pyridin-3-yl]-ethane-1,2-dione |
US20060100432A1 (en) * | 2004-11-09 | 2006-05-11 | Matiskella John D | Crystalline materials of 1-(4-benzoyl-piperazin-1-yl)-2-[4-methoxy-7-(3-methyl-[1,2,4]triazol-1-yl)-1H-pyrrolo[2,3-c]pyridin-3-yl]-ethane-1,2-dione |
EP2161275A1 (en) | 2005-01-19 | 2010-03-10 | Rigel Pharmaceuticals, Inc. | Prodrugs of 2,4-pyrimidinediamine compounds and their uses |
US7723338B2 (en) * | 2005-01-31 | 2010-05-25 | Bristol-Myers Squibb Company | Crystalline forms of 1-benzoyl-4-[2-[4,7-dimethoxy-1-[(phosphonooxy)methyl]-1H-pyrrolo[2,3-C]pyridin-3-yl]-1,2-dioxoethyl]-piperazine |
US7601715B2 (en) * | 2005-06-22 | 2009-10-13 | Bristol-Myers Squibb Company | Process for preparing triazole substituted azaindoleoxoacetic piperazine derivatives and novel salt forms produced therein |
US7396830B2 (en) | 2005-10-04 | 2008-07-08 | Bristol-Myers Squibb Company | Piperazine amidines as antiviral agents |
US7851476B2 (en) * | 2005-12-14 | 2010-12-14 | Bristol-Myers Squibb Company | Crystalline forms of 1-benzoyl-4-[2-[4-methoxy-7-(3-methyl-1H-1,2,4-triazol-1-YL)-1-[(phosphonooxy)methyl]-1H-pyrrolo[2,3-C]pyridin-3-YL]-1,2-dioxoethyl]-piperazine |
US7501419B2 (en) * | 2006-04-25 | 2009-03-10 | Bristol-Myers Squibb Company | 4-Squarylpiperazine derivatives as antiviral agents |
US7807671B2 (en) | 2006-04-25 | 2010-10-05 | Bristol-Myers Squibb Company | Diketo-piperazine and piperidine derivatives as antiviral agents |
US7504399B2 (en) * | 2006-06-08 | 2009-03-17 | Bristol-Meyers Squibb Company | Piperazine enamines as antiviral agents |
US7572810B2 (en) * | 2006-06-08 | 2009-08-11 | Bristol-Myers Squibb Company | Alkene piperidine derivatives as antiviral agents |
CA2658506C (en) | 2006-07-20 | 2016-01-26 | Affinium Pharmaceuticals, Inc. | Acrylamide derivatives as fab 1 inhibitors |
JP5433690B2 (ja) * | 2008-06-25 | 2014-03-05 | ブリストル−マイヤーズ スクイブ カンパニー | 抗−hiv薬としてのジケト縮合アゾロピペリジンおよびアゾロピペラジン |
US8242124B2 (en) * | 2008-06-25 | 2012-08-14 | Bristol-Myers Squibb Company | Diketopiperidine derivatives as HIV attachment inhibitors |
DK2323633T3 (da) * | 2008-09-04 | 2012-07-09 | Bristol Myers Squibb Co | Stabil, farmaceutisk sammensætning til optimeret indgivelse af en hiv-bindingshæmmer |
US8399513B2 (en) * | 2008-10-20 | 2013-03-19 | Xenoport, Inc. | Levodopa prodrug mesylate hydrate |
EP2349973A2 (en) * | 2008-10-20 | 2011-08-03 | XenoPort, Inc. | Methods of synthesizing a levodopa ester prodrug |
WO2010151711A1 (en) * | 2009-06-25 | 2010-12-29 | Alkermes, Inc. | Prodrugs of nh-acidic compounds |
JP2013520521A (ja) * | 2009-11-09 | 2013-06-06 | ゼノポート,インコーポレーテッド | レボドパプロドラッグの医薬組成物及び経口剤形並びに使用方法 |
US8802661B2 (en) | 2010-06-04 | 2014-08-12 | Bristol-Myers Squibb Company | C-28 amides of modified C-3 betulinic acid derivatives as HIV maturation inhibitors |
CA2801487C (en) | 2010-06-04 | 2017-12-05 | Bristol-Myers Squibb Company | Modified c-3 betulinic acid derivatives as hiv maturation inhibitors |
US8450361B2 (en) | 2010-08-06 | 2013-05-28 | Bristol-Myers Squibb Company | Substituted indole and azaindole oxoacetyl piperazinamide derivatives |
WO2012075235A1 (en) | 2010-12-02 | 2012-06-07 | Bristol-Myers Squibb Company | Alkyl amides as hiv attachment inhibitors |
RS54352B1 (en) | 2011-01-31 | 2016-02-29 | Bristol-Myers Squibb Company | C-28 AMINES OF C-3 MODIFIED BETULINIC ACID DERIVATIVES AS HIV INVESTIGATION INHIBITORS |
EP2670751B1 (en) * | 2011-01-31 | 2015-04-22 | Bristol-Myers Squibb Company | Methods of making hiv attachment inhibitor prodrug compound and intermediates |
CA2826113C (en) | 2011-01-31 | 2018-09-04 | Bristol-Myers Squibb Company | C-17 and c-3 modified triterpenoids with hiv maturation inhibitory activity |
EP2696937B1 (en) | 2011-04-12 | 2017-05-17 | VIIV Healthcare UK (No.5) Limited | Thioamide, amidoxime and amidrazone derivatives as hiv attachment inhibitors |
ES2609579T3 (es) | 2011-08-29 | 2017-04-21 | VIIV Healthcare UK (No.5) Limited | Derivados espiro de diamina bicíclica como inhibidores de la unión del VIH |
US8835454B2 (en) | 2011-08-29 | 2014-09-16 | Bristol-Myers Squibb Company | Fused bicyclic diamine derivatives as HIV attachment inhibitors |
KR20140069167A (ko) | 2011-09-21 | 2014-06-09 | 브리스톨-마이어스 스큅 컴퍼니 | 항바이러스 활성을 갖는 신규 베툴린산 유도체 |
US20140356863A1 (en) | 2011-11-21 | 2014-12-04 | Bristol-Myers Squibb Company | Methods for determining the susceptibility of a virus to an attachment inhibitor |
US8426450B1 (en) * | 2011-11-29 | 2013-04-23 | Helsinn Healthcare Sa | Substituted 4-phenyl pyridines having anti-emetic effect |
US9248139B2 (en) | 2011-12-21 | 2016-02-02 | Bristol-Myers Squibb Company | Co-processing method and formulations for HIV attachment inhibitor prodrug compound and excipients |
CN104080785B (zh) * | 2012-02-08 | 2016-08-31 | 百时美施贵宝公司 | 用于制备hiv附着抑制剂哌嗪前药化合物的方法 |
US8906889B2 (en) | 2012-02-15 | 2014-12-09 | Bristol-Myers Squibb Company | C-3 cycloalkenyl triterpenoids with HIV maturation inhibitory activity |
WO2013138436A1 (en) | 2012-03-14 | 2013-09-19 | Bristol-Myers Squibb Company | Cyclolic hydrazine derivatives as hiv attachment inhibitors |
US8889854B2 (en) | 2012-05-07 | 2014-11-18 | Bristol-Myers Squibb Company | C-17 bicyclic amines of triterpenoids with HIV maturation inhibitory activity |
WO2013190384A1 (en) | 2012-06-19 | 2013-12-27 | Affinium Pharmaceuticals, Inc. | Prodrug derivatives of (e)-n-methyl-n-((3-methylbenzofuran-2-yl)methyl)-3-(7-oxo-5,6,7,8-tetrahydro-1,8-naphthyridin-3-yl)acrylamide |
EP2895471B1 (en) | 2012-08-09 | 2016-11-23 | VIIV Healthcare UK (No.5) Limited | Piperidine amide derivatives as hiv attachment inhibitors |
WO2014025852A1 (en) | 2012-08-09 | 2014-02-13 | Bristol-Myers Squibb Company | Tricyclic alkene derivatives as hiv attachment inhibitors |
EP2953960A1 (en) | 2013-02-06 | 2015-12-16 | Bristol-Myers Squibb Company | C-19 modified triterpenoids with hiv maturation inhibitory activity |
CN105102468A (zh) | 2013-02-25 | 2015-11-25 | 百时美施贵宝公司 | 用于治疗hiv的c-3烷基和烯基修饰的桦木酸衍生物 |
US20160052923A1 (en) * | 2013-03-27 | 2016-02-25 | Bristol-Myers Squibb Company | Piperazine and homopiperazine derivatives as hiv attachment inhibitors |
WO2014160692A1 (en) * | 2013-03-27 | 2014-10-02 | Bristol-Myers Squibb Company | 2-keto amide derivatives as hiv attachment inhibitors |
CA2944778C (en) | 2014-04-11 | 2022-06-14 | ViiV Healthcare UK (No.4) Limited | Triterpenoids with hiv maturation inhibitory activity |
WO2015195776A1 (en) | 2014-06-19 | 2015-12-23 | Bristol-Myers Squibb Company | Betulinic acid derivatives with hiv maturation inhibitory activity |
KR20170092581A (ko) | 2014-11-14 | 2017-08-11 | 비브 헬스케어 유케이 (넘버5) 리미티드 | C17-아릴 치환된 베툴린산 유사체 |
US9969767B2 (en) | 2014-11-14 | 2018-05-15 | VIIV Healthcare UK (No.5) Limited | Oxolupene derivatives |
AU2015364600B2 (en) | 2014-12-18 | 2018-05-10 | ViiV Healthcare UK (No.4) Limited | A process for preparing halogenated azaindole compounds using boroxine |
KR20170097145A (ko) | 2014-12-18 | 2017-08-25 | 비브 헬스케어 유케이 (넘버4) 리미티드 | Pybrop를 사용하여 할로겐화된 아자인돌 화합물을 제조하는 방법 |
AU2016248235A1 (en) | 2015-04-14 | 2017-10-19 | Viiv Healthcare Uk (No 4) Limited | Crystalline forms of modified triterpenoid hydrochloride salts with HIV maturation inhibitor activity |
CN108366996B (zh) | 2015-10-01 | 2021-04-09 | 奥列马制药公司 | 四氢-1H-吡啶[3,4-b]吲哚类抗雌激素药物 |
US10308671B2 (en) * | 2015-12-14 | 2019-06-04 | Max-Planck-Gesellschaft Zur Forderung | Water-soluble derivatives of 3,5-diphenyl-diazole compounds |
AR107512A1 (es) | 2016-02-04 | 2018-05-09 | VIIV HEALTHCARE UK Nº 5 LTD | Triterpenoides modificados en c-3 y c-17 como inhibidores del vih-1 |
WO2017134598A1 (en) | 2016-02-04 | 2017-08-10 | VIIV Healthcare UK (No.5) Limited | Fostemsavir for use in heavily treatment-experienced hiv-1 infected individuals |
MX2018010254A (es) | 2016-02-26 | 2018-12-19 | Debiopharm Int Sa | Medicamento para el tratamiento de infecciones de pie diabetico. |
KR102395451B1 (ko) | 2017-11-21 | 2022-05-09 | 화이자 인코포레이티드 | 4-(4-(1-이소프로필-7-옥소-1,4,6,7-테트라히드로스피로[인다졸-5,4'-피페리딘]-1'-카르보닐)-6-메톡시피리딘-2-일)벤조산의 결정질 2-아미노-2-(히드록시메틸)프로판-1,3-디올 염 |
EP3911651B1 (en) | 2019-01-17 | 2024-01-10 | ViiV Healthcare UK (No.4) Limited | Process for preparing fostemsavir |
WO2023114951A1 (en) | 2021-12-17 | 2023-06-22 | Viiv Healthcare Company | Combination therapies for hiv infections and uses thereof |
US20240166728A1 (en) | 2022-11-02 | 2024-05-23 | VIIV Healthcare UK (No.5) Limited | Antigen binding proteins |
Family Cites Families (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5619238A (en) | 1992-07-24 | 1997-04-08 | Canon Kabushiki Kaisha | Method of making replaceable ink cartridge |
US6469006B1 (en) * | 1999-06-15 | 2002-10-22 | Bristol-Myers Squibb Company | Antiviral indoleoxoacetyl piperazine derivatives |
US6476034B2 (en) | 2000-02-22 | 2002-11-05 | Bristol-Myers Squibb Company | Antiviral azaindole derivatives |
US20020061892A1 (en) | 2000-02-22 | 2002-05-23 | Tao Wang | Antiviral azaindole derivatives |
WO2002004440A1 (en) * | 2000-07-10 | 2002-01-17 | Bristol-Myers Squibb Company | Composition and antiviral activity of substituted indoleoxoacetic piperazine derivatives |
US20030069266A1 (en) * | 2001-02-02 | 2003-04-10 | Tao Wang | Composition and antiviral activity of substituted azaindoleoxoacetic piperazine derivatives |
US20030207910A1 (en) | 2001-02-02 | 2003-11-06 | Tao Wang | Composition and antiviral activity of substituted azaindoleoxoacetic piperazine derivatives |
US20040110785A1 (en) | 2001-02-02 | 2004-06-10 | Tao Wang | Composition and antiviral activity of substituted azaindoleoxoacetic piperazine derivatives |
AU2003215469A1 (en) | 2002-03-28 | 2003-10-13 | Procyon Biopharma Inc. | Pyridoxal-5-phosphate derivatives as hiv integrase inhibitors |
US7745625B2 (en) * | 2004-03-15 | 2010-06-29 | Bristol-Myers Squibb Company | Prodrugs of piperazine and substituted piperidine antiviral agents |
US7776863B2 (en) | 2004-03-24 | 2010-08-17 | Bristol-Myers Squibb Company | Methods of treating HIV infection |
US7130185B2 (en) * | 2004-06-02 | 2006-10-31 | Research In Motion Limited | Handheld computing device having drop-resistant LCD display |
US7723338B2 (en) * | 2005-01-31 | 2010-05-25 | Bristol-Myers Squibb Company | Crystalline forms of 1-benzoyl-4-[2-[4,7-dimethoxy-1-[(phosphonooxy)methyl]-1H-pyrrolo[2,3-C]pyridin-3-yl]-1,2-dioxoethyl]-piperazine |
US7851476B2 (en) * | 2005-12-14 | 2010-12-14 | Bristol-Myers Squibb Company | Crystalline forms of 1-benzoyl-4-[2-[4-methoxy-7-(3-methyl-1H-1,2,4-triazol-1-YL)-1-[(phosphonooxy)methyl]-1H-pyrrolo[2,3-C]pyridin-3-YL]-1,2-dioxoethyl]-piperazine |
EP2670751B1 (en) * | 2011-01-31 | 2015-04-22 | Bristol-Myers Squibb Company | Methods of making hiv attachment inhibitor prodrug compound and intermediates |
CN104080785B (zh) * | 2012-02-08 | 2016-08-31 | 百时美施贵宝公司 | 用于制备hiv附着抑制剂哌嗪前药化合物的方法 |
-
2005
- 2005-02-25 US US11/066,745 patent/US7745625B2/en active Active
- 2005-03-03 NZ NZ549867A patent/NZ549867A/en unknown
- 2005-03-03 GE GEAP20059660A patent/GEP20094736B/en unknown
- 2005-03-03 PL PL05724510T patent/PL1725569T3/pl unknown
- 2005-03-03 DK DK05724510T patent/DK1725569T3/da active
- 2005-03-03 DE DE602005004517T patent/DE602005004517T2/de active Active
- 2005-03-03 CA CA2560253A patent/CA2560253C/en active Active
- 2005-03-03 RS RSP-2008/0060A patent/RS50567B/sr unknown
- 2005-03-03 WO PCT/US2005/006980 patent/WO2005090367A1/en active Application Filing
- 2005-03-03 PT PT05724510T patent/PT1725569E/pt unknown
- 2005-03-03 AU AU2005223736A patent/AU2005223736C1/en active Active
- 2005-03-03 EP EP05724510A patent/EP1725569B1/en active Active
- 2005-03-03 AT AT05724510T patent/ATE384728T1/de active
- 2005-03-03 JP JP2007503935A patent/JP4734318B2/ja active Active
- 2005-03-03 ES ES05724510T patent/ES2299022T3/es active Active
- 2005-03-03 NZ NZ585294A patent/NZ585294A/en unknown
- 2005-03-03 KR KR1020067021381A patent/KR101153594B1/ko active IP Right Grant
- 2005-03-03 CN CN2010101669503A patent/CN101941990B/zh active Active
- 2005-03-03 BR BRPI0508876A patent/BRPI0508876B8/pt active IP Right Grant
- 2005-03-09 TW TW094107202A patent/TWI344843B/zh active
- 2005-03-12 MY MYPI20051051A patent/MY139243A/en unknown
- 2005-03-15 AR ARP050100996A patent/AR048039A1/es active IP Right Grant
- 2005-03-15 PE PE2005000289A patent/PE20051151A1/es active IP Right Grant
-
2006
- 2006-09-08 NO NO20064062A patent/NO336742B1/no unknown
-
2007
- 2007-04-20 HK HK07104164A patent/HK1096687A1/xx unknown
-
2008
- 2008-02-11 HR HR20080064T patent/HRP20080064T5/xx unknown
- 2008-04-21 CY CY20081100447T patent/CY1107419T1/el unknown
-
2010
- 2010-04-26 US US12/767,222 patent/US8168615B2/en active Active
-
2011
- 2011-03-15 HK HK11102611.2A patent/HK1148533A1/xx unknown
- 2011-03-27 IL IL211961A patent/IL211961A/en active IP Right Grant
-
2012
- 2012-03-26 US US13/429,838 patent/US8461333B2/en active Active
-
2013
- 2013-04-12 US US13/861,804 patent/US8871771B2/en active Active
-
2014
- 2014-04-10 US US14/249,638 patent/US20150025240A1/en not_active Abandoned
-
2015
- 2015-05-05 US US14/704,183 patent/US20150232414A1/en not_active Abandoned
- 2015-07-15 US US14/800,315 patent/US20150315218A1/en not_active Abandoned
-
2016
- 2016-08-29 US US15/249,827 patent/US20160361328A1/en not_active Abandoned
-
2017
- 2017-09-14 US US15/704,100 patent/US20180000849A1/en not_active Abandoned
-
2018
- 2018-11-14 US US16/190,632 patent/US20190111066A1/en not_active Abandoned
-
2019
- 2019-10-22 US US16/659,786 patent/US20200046743A1/en not_active Abandoned
-
2020
- 2020-10-13 US US17/068,902 patent/US11369624B2/en active Active
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HRP20080064T5 (en) | Prodrugs of piperazine and substituted piperidine antiviral agents | |
RS51949B (en) | INHIBITORI KINAZE | |
RS51674B (en) | PIPERIDIN-4-IL-PIRIDAZIN-3-ILAMINE DERIVATIVES AS A FAST DISSOCATING DOPAMIN 2 RECEIVER ANTAGONISTS | |
RS53021B (en) | INDOLIC, AZAINDOL AND RELATED HETEROCYCLIC 4-ALKENYL PIPERIDINE AMIDES | |
RS53153B (en) | ANTAGONISTS OF HYSTAMINE -3 RECEPTORS | |
HRP20070510T3 (en) | Benzimidazole derivative and its use as a ii receptor antagonist | |
RS52562B (en) | (3-ARIL-PIPERAZINE-1-IL) DERIVATI 6,7-DIALCOKSIQUINZOLINE, 6,7-DIALCOKSIFTALAZINE I | |
HRP20020175B1 (en) | N-heterocyclikc derivatives as nos inhibitors | |
MEP22008A (en) | Derivatives of n-[heteroaryl(piperidine-2-yl)methyl]benzamide, preparation method thereof and application of same in therapeutics | |
RS51995B (en) | NEW UNITS AS OPIOID RECEPTOR MODULATORS | |
RS54260B1 (en) | AMINODIHYDROTIAZINE DERIVATIVES AS BACE INHIBITORS FOR ALZHEIMER DISEASE TREATMENT | |
RS52489B (en) | COMPOSITION AND ANTI-VIRUS ACTIVITY OF DERIVATIVES OF SUBSTITUTED AZAINDOLOXSOACETATE PIPERAZINE | |
RS51385B (en) | HETEROAROMATIC COMPOUNDS OF HINOLINE AND THEIR USE AS PDE10 INHIBITORS | |
MEP10709A (en) | 2-ARYL-6-PHENYLIMIDAZO[1,2-alpha]PYRIDINE DERIVATIVES, PREPARATION THEREOF AND THERAPEUTIC USE THEREOF | |
HRP20041008B1 (hr) | Derivati triazola kao antagonisti receptora tahikinina | |
RS52702B (en) | CARBASOL UNITS AND THERAPEUTIC USE OF THE COMPOUNDS | |
CO5280070A1 (es) | Compuestos, composiciones farmaceuticas de indazol y metodos para mediar o inhibir la proliferacion celular | |
RS52545B (en) | INHIBITORI PROTEIN APOPTOZE (IAP) | |
RS52326B (en) | Phenyl-piperazine Derivatives As Serotonin Resorption Inhibitors | |
DE60026514D1 (de) | Neue prolinverbindungen als mikrobizide mittel | |
RS53038B (en) | OXADIAZOLA DERIVATIVE Activate Sphingosine-1-Phosphate (SIP) | |
RS52191B (en) | TETRAHYDROCYCLOPENT (B) INDOLE UNITS AS MODULATORS OF ANDROGENIC RECEPTORS | |
WO2002094794A8 (en) | 4 (phenyl-piperazinyl-methyl) benzamide derivatives and their use for the treatment of pain anxiety or gastrointestinal disorders | |
HRP20100433T1 (hr) | Diazaindol-dikarbonil-piperazinil antivirotici | |
WO2009156864A3 (en) | Substituted alkyl pyrimidin-4-one derivatives |